ADHD and Tic Disorders: Discussing the SATURN Trial

May 13, 09:19 AM

In this In Conversation podcast, Dr. Seonaid Anderson is joined by Professor Chris Hollis, who is leading a research team working on a research project about ADHD medication and Tics. The focus of this podcast is on this research project, called The SATURN Trial.

DOI: 10.13056/acamh.27603

In this In Conversation podcast, Dr. Seonaid Anderson is joined by Professor Chris Hollis, who is leading a research team working on a research project about ADHD medication and Tics. The focus of this podcast is on this research project, called The SATURN Trial.

The full name of the trial is the ‘Stimulant Medication for ADHD and Tics – Understanding Response versus Non-stimulants (SATURN): a randomised trial of the clinical and cost-effectiveness of methylphenidate versus Guanfacine for ADHD in children and young people with a co-existing tic disorder’.

Discussion points include:

  • Definition of Tics and ADHD.
  • Potential challenges of differentiating between tics from a Tic Disorder, such as Tourette Syndrome, from other movements from conditions such as chorea dystonia myoclonus.
  • Differentiating between stimming movements and tics.
  • The reason behind The SATURN Trial and how it is funded.
  • The effectiveness of non-stimulant medication in treating the symptoms of ADHD.
  • Co-morbidity and Tic Disorders.
  • Impact of the ongoing shortage of ADHD medication on patients.
  • Why people should be encouraged to get involved in this research and the clinical implications from this research.
This episode is part of The Association for Child and Adolescent Mental Health’s series on Tourette Syndrome and Tic Disorders. The series explores the evidence-based research on Tourette Syndrome, and other Tic Disorders, as well as the education, treatments, and research in this area.

#ListenLearnLike